947.5000 -2.00 (-0.21%)
NSE Aug 12, 2025 15:58 PM
Volume: 31,337
 

947.50
-0.21%
BOB Capital Markets Ltd.
Revenue/EBITDA/ PAT grew 6.7%/8% and 19% above our estimates. EBITDA margin reported 20bps above estimates of 15.4% in 4QFY25
Alembic Pharmaceuticals Ltd. is trading above its 150 day SMA of 930.2
More from Alembic Pharmaceuticals Ltd.
Recommended